The antibody of prostate-specific membrane antigen (PSMA) was recently used by Mahmoudifard et al. to label GQDs obtained from graphite in order to develop a fluorescent immunosensor able to detect prostate cancer (PCa) derived exosomes from blood serum [110]. Here, FOLH1 is linked to prostate carcinoma.